Non-surgical skin tightening is the “holy grail” of plastic surgery, and Ellacor is the latest and greatest step toward it.
Since conducting the clinical trials for Ellacor, Florida plastic surgeon Dr. Jason Pozner has treated hundreds of patients – including himself!
By punching out numerous tiny cylinders of loose skin and stimulating the surrounding skin’s healing response, Ellacor is designed to reduce laxity and generate healthier skin without leaving any scars.
Dr. Pozner joins Dr. Bass to discuss what it does, how it works, and how it was developed.
Listen as Drs. Bass and Pozner discuss downtime, aftercare, what they think about what it can and cannot do, and who the ideal patients are for this innovative new technology.
About Dr. Lawrence Bass
Innovator. Industry veteran. In-demand Park Avenue board certified plastic surgeon, Dr. Lawrence Bass is a true master of his craft, not only in the OR but as an industry pioneer in the development and evaluation of new aesthetic technologies. With locations in both Manhattan (on Park Avenue between 62nd and 63rd Streets) and in Great Neck, Long Island, Dr. Bass has earned his reputation as the plastic surgeon for the most discerning patients in NYC and beyond.
To learn more, visit the Bass Plastic Surgery website at https://www.drbass.net/ or follow the team on Instagram @drbassnyc https://www.instagram.com/drbassnyc/
Subscribe to the Park Avenue Plastic Surgery Class newsletter to be notified of new episodes & receive exclusive invitations, offers, and information from Dr. Bass.
https://lp.constantcontactpages.com/su/TpLxzW8/podcast
Contents of this video:
00:00 - Intro
01:28 - How does Ellacor work?
03:01 - How has Ellacor evolved?
06:18 - What happens during an Ellacor treatment?
08:54 - Recovery after Ellacor
11:51 - How much improvement will I see after Ellacor?
13:10 - What does Ellacor treat?
16:20 - How many Ellacor treatments do I need?
19:21 - Does Ellacor help with wrinkles?
20:22 - Who is a candidate for Ellacor?
22:03 - Ellacor vs. other nonsurgical alternatives
22:29 - Takeaways
